Scholars Central

Conference abstractPublished 28 Nov 2013

Pregabalin: Use, misuse and abuse

Authors: Georgios Papazisis

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Pregabalin is a prescription drug approved for the treatment of generalized anxiety disorder; partial epilepsy; peripheral and central neuropathic pain; and has been recently approved by the FDA for the treatment of fibromyalgia. It has also been studied in clinical trials for its potential as a replacement therapy for alcohol and benzodiazepine addiction. Pregabalin is an alpha-2-delta ligand, structurally related to the neurotransmitter GABA. Similar to other compounds modulating GABA-ergic neurotransmission (e.g. benzodiazepines), there is some concern about its potential to cause addiction. However, the results of premarketing trials have been conflicting in this respect and thus pregabalin has been classified as a Schedule V drug by the US Drug Enforcement Administration, indicating that it has low abuse potential. Following the rapidly increasing use of pregabalin, data signaling its abuse liability have been published recently. Currently, these data are limited to two cross-over randomized control trials, one database analysis, one analysis of anecdotal online reports and a few case reports. Aim of the presentation is to highlight the potential for abuse of pregabalin, especially in patients with a history of substance-seeking behavior. Considering that the drug has recently been proposed as a treatment for substance misuse, namely for both alcohol and benzodiazepine-dependent individuals, a better clarification of its abuse potential is essential in order to characterize its extent and nature.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Similar by topic

More from this journal

The newest in Clinical Pharmacology & Biopharmaceutics.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalClinical Pharmacology & Biopharmaceutics
  • SubjectPharmaceutical Sciences
  • BylineArticles whose byline prints “Georgios Papazisis”

For authors and organisers

Publish, present and keep up with your field

Find the right journal for your paper and submit your manuscript.

Photo: Pexels